Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene.
Double blind controlled study on fifty treatment-resistant schizophrenic inpatients showed a statistically significant improvement in favour of the high dose group.
Huang
C C
CC
Medical College of Wisconsin.
Gerhardstein
R P
RP
Kim
D Y
DY
Hollister
L
L
D000328:Adult; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D013888:Thiothixene / Q000627:therapeutic use*
D013888:Thiothixene